Press Releases.

Month Year

Month Year

Investor Alerts

November 08, 2018

Regulus Reports Third Quarter 2018 Financial Results and Recent Updates

$47 Million Restructured Sanofi Collaboration Executed
November 06, 2018

Regulus Announces Successful Restructuring of Sanofi Collaboration

Sanofi Will Assume Development of RG-012 for Alport syndrome
October 25, 2018

Regulus to Present Data from ATHENA, a Global Natural History of Disease Study for Alport Syndrome, at ASN's Kidney Week 2018
October 22, 2018

Regulus to Present Preclinical Data Supporting RGLS4326 as a Novel Therapeutic in Development for Autosomal Dominant Polycystic Kidney Disease at ASN's Kidney Week 2018
October 18, 2018

Regulus Regains Compliance with NASDAQ Listing Requirements

Show per page